Načítá se...
Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: The pharmacokinetics of duloxetine have been assessed in a number of clinical studies. Duloxetine is eliminated through oxidative metabolism via CYP1A2 and, to a lesser degree, CYP2D6. There is strong evidence that the prevalence of CYP2D6 phenotypes and the...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Science Inc
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2000724/ https://ncbi.nlm.nih.gov/pubmed/17380590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02770.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|